Yousefi, Arjen https://orcid.org/0009-0007-2198-2137
Levin, Mark-David https://orcid.org/0000-0003-2139-3547
Cornelissen, Jan J.
Westerweel, Peter E. https://orcid.org/0000-0002-0746-7039
Article History
Received: 12 November 2024
Accepted: 27 December 2024
First Online: 10 January 2025
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: The participants have consented to the submission of the case report to the journal.
: Arjen Yousefi, Mark-David Levin and Jan J. Cornelissen declare no conflict of interests. Peter E. Westerweel has received research support and consultant fees from BMS/Celgene and Novartis.